Technical Analysis for BTTX - Better Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Narrow Range Bar | Range Contraction | 0.00% | |
Earnings Movers | Other | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
New 52 Week Closing Low | Bearish | 8.53% | |
Narrow Range Bar | Range Contraction | 8.53% | |
Wide Bands | Range Expansion | 8.53% | |
Down 3 Days in a Row | Weakness | 8.53% | |
Oversold Stochastic | Weakness | 8.53% |
Alert | Time |
---|---|
Possible Inside Day | about 17 hours ago |
Down 1% | about 18 hours ago |
60 Minute Opening Range Breakdown | about 19 hours ago |
Up 5% | about 21 hours ago |
Up 3% | about 21 hours ago |
Get a Trading Assistant
- Earnings date: 03/28/2024
Better Therapeutics, Inc. Description
Better Therapeutics is a prescription digital therapeutics (PDT) company developing a novel form of cognitive behavioral therapy to address the root causes of cardiometabolic diseases. The company has developed a proprietary platform for the development of FDA-regulated, software-based solutions for type 2 diabetes, heart disease and other conditions. The cognitive behavioral therapy delivered by Better Therapeutics’ PDT is designed to enable changes in neural pathways of the brain so lasting changes in behavior become possible. Addressing the underlying causes of these diseases has the potential to dramatically improve patient health while lowering healthcare costs. Better Therapeutics clinically validated mobile applications are intended to be prescribed by physicians and reimbursed like traditional medicines.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Disease Health Sciences Diabetes FDA Health Informatics Heart Disease Healthcare Costs Behavior Modification Digital Therapeutics
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 1.61 |
52 Week Low | 0.012 |
Average Volume | 7,177,518 |
200-Day Moving Average | 0.39 |
50-Day Moving Average | 0.15 |
20-Day Moving Average | 0.10 |
10-Day Moving Average | 0.02 |
Average True Range | 0.02 |
RSI (14) | 27.01 |
ADX | 34.98 |
+DI | 14.22 |
-DI | 36.22 |
Chandelier Exit (Long, 3 ATRs) | 0.15 |
Chandelier Exit (Short, 3 ATRs) | 0.08 |
Upper Bollinger Bands | 0.27 |
Lower Bollinger Band | -0.08 |
Percent B (%b) | 0.26 |
BandWidth | 354.56 |
MACD Line | -0.05 |
MACD Signal Line | -0.04 |
MACD Histogram | -0.0073 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.02 | ||||
Resistance 3 (R3) | 0.02 | 0.02 | 0.02 | ||
Resistance 2 (R2) | 0.02 | 0.02 | 0.02 | 0.02 | |
Resistance 1 (R1) | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
Pivot Point | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Support 1 (S1) | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Support 2 (S2) | 0.01 | 0.01 | 0.01 | 0.01 | |
Support 3 (S3) | 0.01 | 0.01 | 0.01 | ||
Support 4 (S4) | 0.01 |